Výpis publikací

GOTTUMUKKALA, Narendra Varma; Jakub POSPÍŠIL a Michal ŠMÍDA. FORMATION OF TUNNELING NANOTUBES IN CHRONIC LYMPHOCYTIC LEUKEMIA AND ASSOCIATED MITOCHONDRIAL TRANSFER TRIGGER (CAR)-T CELL EXHAUSTION. In EHA2025 congress, Italy. 2025.

LADUNGOVÁ, Adriana; Filio STYLIANOU; Helena PESCHELOVÁ; Yusuf LODHI; Lenka DOSTÁLOVÁ; Narendra Varma GOTTUMUKKALA a Michal ŠMÍDA. EXPLORING VENETOCLAX RESISTANCE MECHANISMS IN AML CELLS THROUGH GENOME-WIDE CRISPR SCREENS AND DRUG PROFILING. In III. ČESKÝ HEMATOLOGICKÝ A TRANSFUZIOLOGICKÝ SJEZD in Transfuze a Hematologie Dnes. 2024.

LADUNGOVÁ, Adriana; Helena PESCHELOVÁ; Lenka DOSTÁLOVÁ; Yusuf LODHI; Narendra Varma GOTTUMUKKALA; Jiří MAYER a Michal ŠMÍDA. Exploring the mechanisms of Venetoclax resistence via drug screening and genome-wide CRISPR screening. In The 65th ASH Annual Meeting and Exposition, San Diego, California, USA in Blood. 2023.

GOTTUMUKKALA, Narendra Varma; Aneta LEDEREROVÁ; Lenka DOSTÁLOVÁ; Adriana LADUNGOVÁ; Yusuf LODHI a Michal ŠMÍDA. Chasing the epigenetic landscape to enhance CAR-T cell activity py preventing CD19 antigen escape in relapsed models. In EHA Meeting – 5th European CAR T-cell Meeting, Rotterdam, Nizozemsko. 2023.

DOSTÁLOVÁ, Lenka; Adriana LADUNGOVÁ; Dominika ŠKRNOVÁ; Narendra Varma GOTTUMUKKALA; Yusuf LODHI a Michal ŠMÍDA. Combined drug and CRISPR/CAS9 screening reveals specific targets for SF3B1- and NOTCH1- mutated CLL cells. In EHA 2022 in HemaSphere 2022; 6(S3): 1012-1013. 2022.

GOTTUMUKKALA, Narendra Varma; Veronika MANČÍKOVÁ; Aneta LEDEREROVÁ; Veronika KOZLOVÁ; Lenka DOSTÁLOVÁ; Adriana LADUNGOVÁ; Yusuf LODHI; Jan VERNER a Michal ŠMÍDA. Chasing the epigenetic landscape to enhance CAR-T cell activity by preventing CD19 antigen escape in relapsed models. In XVII. Myeloma and Cell Therapy Workshop, Ostrava. 2022.

GOTTUMUKKALA, Narendra Varma; Veronika MANČÍKOVÁ; Aneta LEDEREROVÁ; Veronika KOZLOVÁ; Lenka DOSTÁLOVÁ; Adriana LADUNGOVÁ; Yusuf LODHI; Jan VERNER a Michal ŠMÍDA. Chasing the epigenetic landscape to enhance CAR-T cell activity by preventing CD19 antigen escape in relapsed models. In Annual PhD conference Biomedical sciences, Brno. 2022.